Results 111 to 120 of about 1,076 (281)

DCAF13 Safeguards Hematopoietic Stem Cells via RRS1‐Regulated Ribosome Biogenesis

open access: yesAdvanced Science, EarlyView.
This study establishes DCAF13 as an essential regulator for hematopoietic stem cell (HSC) function. Its deletion in mice causes lethal pancytopenia and HSC depletion. Mechanistically, DCAF13 interacts with RRS1 and mediates its non‐degradative K27‐linked ubiquitination, thereby stabilizing RRS1 to maintain ribosome biogenesis and protein translation ...
Mengke Li   +25 more
wiley   +1 more source

A Nanoparticle‐Integrated Complete Manufacturing Pipeline of Chemically Engineered Exosomes

open access: yesAdvanced Science, EarlyView.
We report a novel manufacture technology of chemically engineered exosomes. The four steps of manufacturing, i.e., biogenesis, loading, isolation, and storage, are integrated by the use of a nanoparticle. The manufacture technology incorporates three innovative components, i.e., a new nano‐bio effect, a new composite nanoparticle, and a new isolation ...
Xiaowei Wen   +13 more
wiley   +1 more source

GPCRs in CAR‐T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy

open access: yesAdvanced Science, EarlyView.
Chimeric antigen receptor T cell therapy faces dual challenges of target scarcity and an immunosuppressive microenvironment in solid tumors. This review highlights how G protein‐coupled receptors can serve as both novel targets to expand the therapeutic scope and functional modules to enhance CAR‐T cell efficacy.
Zhuoqun Liu   +11 more
wiley   +1 more source

A rare case of Good’s syndrome presented with recurrent COVID pneumonia

open access: yesThe Journal of Association of Chest Physicians
A 45-year-old male patient with a history of thymectomy presented to the emergency with a history of cough, breathlessness, and fever for the past 3 days. He had undergone a thymectomy in the year 2017 for a thymoma.
Udvass Kumar Kotokey
doaj   +1 more source

Combination Immunotherapy as a Promising Strategy to Overcome Immunotherapy Resistance: From Emergence to Next‐Generation Approaches

open access: yesAdvanced Science, EarlyView.
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey   +6 more
wiley   +1 more source

Significant decreased CXCR3+ phenotype Tfh1 cells in three Good’s syndrome patients

open access: yesFrontiers in Immunology
BackgroundGood’s syndrome (GS) is a rare acquired immunodeficiency defined by the co-occurrence of thymoma and hypogammaglobulinemia. Follicular helper T (Tfh) cells, a specialized CD4+ T cell subset, play a critical role in supporting B-cell antibody ...
Yanxia Chen   +5 more
doaj   +1 more source

Delayed Diagnosis of Good Syndrome

open access: yesThe Journal of Allergy and Clinical Immunology: In Practice, 2020
Jessica D, Gereige   +2 more
openaire   +3 more sources

Montana Kaimin, April 8, 1986 [PDF]

open access: yes, 1986
Student newspaper of the University of Montana, Missoula.https://scholarworks.umt.edu/studentnewspaper/8872/thumbnail ...
Associated Students of the University of Montana
core   +1 more source

Autoimmune Encephalitis in Acute Care—Pathology, Diagnosis, and Management

open access: yesAdvanced Science, EarlyView.
ABSTRACT Autoimmune encephalitis (AE) is characterized by immune‐mediated inflammation of the brain parenchyma, presenting with various neurological syndromes, including but not limited to seizures, altered consciousness, neuropsychiatric symptoms, and movement disorders.
Suneesh Thilak   +9 more
wiley   +1 more source

Immunological Tolerance: One of Biology's Most Intriguing Mysteries [PDF]

open access: yes, 1999
Bach FH   +48 more
core   +1 more source

Home - About - Disclaimer - Privacy